200 related articles for article (PubMed ID: 23069256)
1. Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma.
Lin KJ; Lin TM; Wang CH; Liu HC; Lin YL; Eng HL
Hum Pathol; 2013 Apr; 44(4):534-41. PubMed ID: 23069256
[TBL] [Abstract][Full Text] [Related]
2. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
4. Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells.
Chang S; Kodys K; Szabo G
Hepatology; 2010 Jan; 51(1):35-42. PubMed ID: 19821521
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.
Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS
Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
[TBL] [Abstract][Full Text] [Related]
7. Suppression of furin by interferon-γ and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes.
Wu JF; Hsu HY; Ni YH; Chen HL; Wu TC; Chang MH
Am J Pathol; 2012 Jul; 181(1):19-25. PubMed ID: 22634051
[TBL] [Abstract][Full Text] [Related]
8. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
9. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
[TBL] [Abstract][Full Text] [Related]
10. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.
Das D; Sengupta I; Sarkar N; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakrabarti S; Chakravarty R
BMC Infect Dis; 2017 Jan; 17(1):76. PubMed ID: 28088184
[TBL] [Abstract][Full Text] [Related]
11. Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure.
Zhang C; Fan L; Fan T; Wu D; Gao L; Ling Y; Zhu J; Li R; Wei L
Cell Biochem Biophys; 2013 Mar; 65(2):187-95. PubMed ID: 22907585
[TBL] [Abstract][Full Text] [Related]
12. TNF-α Induced by Hepatitis C Virus via TLR7 and TLR8 in Hepatocytes Supports Interferon Signaling via an Autocrine Mechanism.
Lee J; Tian Y; Chan ST; Kim JY; Cho C; Ou JH
PLoS Pathog; 2015 May; 11(5):e1004937. PubMed ID: 26023919
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
14. Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.
Hu H; Ding X; Yang Y; Zhang H; Li H; Tong S; An X; Zhong Q; Liu X; Ma L; Liu Q; Liu B; Lu Z; Zhang D; Hu P; Ren H
Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G611-22. PubMed ID: 24994855
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling.
Bose S; Sakhuja P; Bezawada L; Agarwal AK; Kazim SN; Khan LA; Sarin SK; Ramakrishna G
J Gastroenterol Hepatol; 2011 Jan; 26(1):135-44. PubMed ID: 21175807
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method.
Lee SY; Song KH; Koo I; Lee KH; Suh KS; Kim BY
Genomics; 2012 Jun; 99(6):347-54. PubMed ID: 22564472
[TBL] [Abstract][Full Text] [Related]
17. The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma.
Nagao M; Nakajima Y; Kanehiro H; Hisanaga M; Aomatsu Y; Ko S; Tatekawa Y; Ikeda N; Kanokogi H; Urizono Y; Kobayashi T; Shibaji T; Kanamura T; Ogawa S; Nakano H
Hepatology; 2000 Sep; 32(3):491-500. PubMed ID: 10960440
[TBL] [Abstract][Full Text] [Related]
18. SiRNA-targeted carboxypeptidase D inhibits hepatocellular carcinoma growth.
Jin T; Fu J; Feng XJ; Wang SM; Huang X; Zhu MH; Zhang SH
Cell Biol Int; 2013 Sep; 37(9):929-39. PubMed ID: 23589395
[TBL] [Abstract][Full Text] [Related]
19. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]